Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2006 1
2007 1
2009 1
2010 3
2011 6
2012 5
2013 6
2014 4
2015 10
2016 7
2017 14
2018 11
2019 16
2020 20
2021 26
2022 35
2023 34
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators. Weitz JI, et al. N Engl J Med. 2017 Mar 30;376(13):1211-1222. doi: 10.1056/NEJMoa1700518. Epub 2017 Mar 18. N Engl J Med. 2017. PMID: 28316279 Free article. Clinical Trial.
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, Li Q, Billot L, Delcourt C, Bath PM, Broderick JP, Demchuk AM, Donnan GA, Durham AC, Lavados PM, Lee TH, Levi C, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Silva F, Song L, Thang NH, Wardlaw JM, Wang JG, Wang X, Woodward M, Chalmers J, Robinson TG; ENCHANTED Investigators and Coordinators. Anderson CS, et al. Lancet. 2019 Mar 2;393(10174):877-888. doi: 10.1016/S0140-6736(19)30038-8. Epub 2019 Feb 7. Lancet. 2019. PMID: 30739745 Clinical Trial.
Pharmacology of Antisense Drugs.
Bennett CF, Baker BF, Pham N, Swayze E, Geary RS. Bennett CF, et al. Among authors: pham n. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:81-105. doi: 10.1146/annurev-pharmtox-010716-104846. Epub 2016 Oct 10. Annu Rev Pharmacol Toxicol. 2017. PMID: 27732800 Review.
New onset of psoriasis following COVID-19 vaccination.
Tran TNA, Nguyen TTP, Pham NN, Pham NTU, Vu TTP, Nguyen HT. Tran TNA, et al. Among authors: pham nn. Dermatol Ther. 2022 Aug;35(8):e15590. doi: 10.1111/dth.15590. Epub 2022 May 26. Dermatol Ther. 2022. PMID: 35583958 Free PMC article. Review.
Persistence of choking injuries in children.
Chang DT, Abdo K, Bhatt JM, Huoh KC, Pham NS, Ahuja GS. Chang DT, et al. Among authors: pham ns. Int J Pediatr Otorhinolaryngol. 2021 May;144:110685. doi: 10.1016/j.ijporl.2021.110685. Epub 2021 Mar 21. Int J Pediatr Otorhinolaryngol. 2021. PMID: 33819896
Nanotechnology- A ray of hope for heavy metals removal.
Mohanapriya V, Sakthivel R, Pham NDK, Cheng CK, Le HS, Dong TMH. Mohanapriya V, et al. Among authors: pham ndk. Chemosphere. 2023 Jan;311(Pt 1):136989. doi: 10.1016/j.chemosphere.2022.136989. Epub 2022 Oct 26. Chemosphere. 2023. PMID: 36309058 Review.
Delivery of cancer therapies by synthetic and bio-inspired nanovectors.
Briolay T, Petithomme T, Fouet M, Nguyen-Pham N, Blanquart C, Boisgerault N. Briolay T, et al. Among authors: nguyen pham n. Mol Cancer. 2021 Mar 24;20(1):55. doi: 10.1186/s12943-021-01346-2. Mol Cancer. 2021. PMID: 33761944 Free PMC article. Review.
Minimal upstream open reading frame of Per2 mediates phase fitness of the circadian clock to day/night physiological body temperature rhythm.
Miyake T, Inoue Y, Shao X, Seta T, Aoki Y, Nguyen Pham KT, Shichino Y, Sasaki J, Sasaki T, Ikawa M, Yamaguchi Y, Okamura H, Iwasaki S, Doi M. Miyake T, et al. Among authors: nguyen pham kt. Cell Rep. 2023 Mar 28;42(3):112157. doi: 10.1016/j.celrep.2023.112157. Epub 2023 Mar 6. Cell Rep. 2023. PMID: 36882059 Free article.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
176 results